Search companies

Live

INTEGRAL DIAGNOSTICS LIMITED (ASX: IDX)

Health care · News and insights

Price unavailable

Latest IDX announcements

Announcement Insights

Integral Diagnostics’ FY26 Growth Meets Workforce Constraints

Integral Diagnostics’ FY26 revenue rose 26% to $789 million and operating profit increased 30% to $165 million, but limited access to radiologists and sonographers constrained its ability to meet demand. The company said strategic and operational changes are planned for FY27; the update reported no new earnings guidance.

Updated 06 Nov 2026, 07:49 AM Sydney time
Share
SourcesChange of Director's Interest Notice - Andy Fay NEDCorrection to App3Y - Andy Fay NEDChange of Director's Interest Notice - Jason Martinez CEOChange in substantial holdingChange of Director's Interest Notice - Dr Kevin Shaw NEDAGM - Chair & CEO PresentationsResults of Annual General Meeting
Comments

Integral Diagnostics Director’s Indirect Shareholding Rises After Correction

2026-11-04 · Health care

IDX: $1.71 -2.85% · MC: $622M

Integral Diagnostics corrected its director-interest notice, confirming Andrew Fay indirectly acquired 60,000 shares through his spouse, bringing her reported holding to 107,000 shares. The correction replaces the original notice’s erroneous prior holding; Fay’s direct and superannuation-trust holdings were unchanged.

Updated 2026-11-04 17:30
Share
SourcesChange of Director's Interest Notice - Andy Fay NEDCorrection to App3Y - Andy Fay NED
Comments

Tribeca Lifts Integral Diagnostics Stake Above 6% as CEO Adds Shares

2026-11-02 · Health care

IDX: $1.76 -0.28% · MC: $622M

Tribeca Investment Partners’ reported voting power in Integral Diagnostics rose from 5.03% to 6.04%, while CEO Jason Martinez acquired additional shares on market, increasing his direct holding from 30,000 to 45,000 shares. The substantial-holder notice lists on-market purchases and sales since its previous filing, but the supplied excerpt does not include the full transaction schedule.

Updated 2026-11-02 17:37
Share
SourcesChange of Director's Interest Notice - Jason Martinez CEOChange in substantial holding
Comments

Integral Diagnostics Director Discloses On-Market Share Purchase

2026-10-30 · Health care

IDX: $1.76 -0.56% · MC: $622M

Integral Diagnostics director Kevin Shaw disclosed an on-market purchase of shares through an account held jointly with Dr Jane Jie Li; the notice reports no change to the disclosed holdings before and after the transaction. The announcement gives the transaction date as November 30, 2026, which is after its October 30 publication date.

Updated 2026-10-30 14:32
Share
SourcesChange of Director's Interest Notice - Dr Kevin Shaw NED
Comments

Integral Diagnostics Shareholders Approve All AGM Resolutions

2026-10-29 · Health care

IDX: $1.77 -14.66% · MC: $622M

Integral Diagnostics shareholders passed all resolutions at its annual general meeting, including the re-election of directors Toby Hall and Ingrid Player and grants of performance rights. In the chair’s address, the company said shortages of radiologists and sonographers continued to constrain its ability to meet demand. The board said management planned strategic and operational changes in the current financial year intended to deliver benefits in future years.

Updated 2026-10-29 15:29
Share
SourcesAGM - Chair & CEO PresentationsResults of Annual General Meeting
Comments